Metraipolis › archive › dc_c2b992b75333

Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal… — Europe PMC PMID:32542003

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32542003
DOI
10.1371/journal.pntd.0008386
License (as archived)
CC0-1.0
Archived
2026-11-08T10:30:40.982Z
SHA-256 of the archived text
c6e125858d948d2712b15f7cd06d184ae2ef82cf9aa9f46d50e73e8845625adc
Stable URL of this page
https://metraipolis.com/documento/dc_c2b992b75333

How to cite

Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal… — Europe PMC PMID:32542003 — Europe PMC (en), https://europepmc.org/article/MED/32542003 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_c2b992b75333 (Metraipolis archive dc_c2b992b75333, sha256 c6e125858d948d2712b15f7cd06d184ae2ef82cf9aa9f46d50e73e8845625adc)
BibTeX
@misc{dcc2b992b75333,
  title = {Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal… — Europe PMC PMID:32542003},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32542003},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_c2b992b75333; sha256 c6e125858d948d2712b15f7cd06d184ae2ef82cf9aa9f46d50e73e8845625adc},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32542003. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Chromoblastomycosis (CBM) is a chronic worldwide subcutaneous mycosis, caused by several dimorphic, pigmented dematiaceous fungi. It is difficult to treat patients with the disease, mainly because of its recalcitrant nature. The correct activation of host immune response is critical to avoid fungal persistence in the tissue and disease chronification. CD4+ T cells are crucial for the development of protective immunity to F. pedrosoi infection. Here, we investigated T helper cell response dynamics during experimental CBM. Following footpad injection with F. pedrosoi hyphae and conidia, T cells were skewed towards a Th17 and Th1 phenotype. The Th17 population was the main Th cell subset found in the infected area during the early stages of experimental murine CBM, followed by Th1 predominance in the later stages, coinciding with the remission phase of the disease in this experimental model. Depletion of CD25+ cells, which leads to a reduction of Treg cells in the draining lymph node, resulted in decline in fungal burden after 14 days of infection. However, fungal cells were not cleared in the later stages of the disease, prolonging CBM clinical features in those animals. IL-17A and IFN-γ neutralization hindered fungal cell elimination in the course of the disease. Similarly, in dectin-2 KO animals, Th17 contraction in the course of experimental CBM was accompanied by fungal burden decrease in the first 14 days of infection, although it did not affect disease resolution. In this study, we gained insight into T helper subsets' dynamics following footpad injections of F. pedrosoi propagules and uncovered their contribution to disease resolution. The Th17 population proved to be important in eliminating fungal cells in the early stages of infection. The Th1 population, in turn, closely assisted by Treg cells, proved to be relevant not only in the elimination of fungal cells at the beginning of infection but also essential for their complete elimination in later stages of the disease in a mouse experimental model of CBM.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2020 (prima pubblicazione 2020-06-15).
Identificativi: PMID 32542003 · PMCID PMC7316354 · DOI 10.1371/journal.pntd.0008386.
Pagina: https://europepmc.org/article/MED/32542003 — https://doi.org/10.1371/journal.pntd.0008386. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T10:26:25.896Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.